Many public health responses and modeled scenarios for COVID-19 outbreaks caused by
SARS-CoV-2 assume that infection results in an immune response that protects individuals …

SARS-CoV-2, the causal agent of COVID-19, first emerged in late 2019 in China. It has since
infected more than 870,000 individuals and caused more than 43,000 deaths globally. Here …

Background The degree to which infection with SARS-CoV-2 confers protection towards
subsequent reinfection is not well described. In 2020, as part of Denmark's extensive, free-of …

Understanding how antibody responses to SARS-CoV-2 evolve during infection may
provide important insight into therapeutic approaches and vaccination for COVID-19. Here …

The SARS-CoV-2 pandemic poses the greatest global public health challenge in a century.
Neutralizing antibody is a correlate of protection and data on kinetics of virus neutralizing …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that first emerged in
late 2019 is responsible for a pandemic of severe respiratory illness. People infected with …

Antibody responses to SARS-CoV-2 can be detected in most infected individuals 10–15 d
after the onset of COVID-19 symptoms. However, due to the recent emergence of SARS …

Background Among the most consequential unknowns of the devastating COVID-19
pandemic are the durability of immunity and time to likely reinfection. There are limited direct …

Understanding adaptive immunity to SARS-CoV-2 is important for vaccine development,
interpreting coronavirus disease 2019 (COVID-19) pathogenesis, and calibration of …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first detected in
Wuhan in December 2019 and caused coronavirus disease 2019 (COVID-19),. In 2003, the …